HK1232159A1 - 用於矯正老視的藥理學眼科用組合物和其施用 - Google Patents

用於矯正老視的藥理學眼科用組合物和其施用

Info

Publication number
HK1232159A1
HK1232159A1 HK17105973.1A HK17105973A HK1232159A1 HK 1232159 A1 HK1232159 A1 HK 1232159A1 HK 17105973 A HK17105973 A HK 17105973A HK 1232159 A1 HK1232159 A1 HK 1232159A1
Authority
HK
Hong Kong
Prior art keywords
presbyopia
pharmacological
administration
correction
ophthalmic composition
Prior art date
Application number
HK17105973.1A
Other languages
English (en)
Inventor
Claes G Feinbaum
Sudhir Patel
Franc Salamun
Original Assignee
Orasis Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orasis Pharmaceuticals Ltd filed Critical Orasis Pharmaceuticals Ltd
Publication of HK1232159A1 publication Critical patent/HK1232159A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK17105973.1A 2014-02-11 2017-06-15 用於矯正老視的藥理學眼科用組合物和其施用 HK1232159A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SI2014/000008 WO2015122853A1 (en) 2014-02-11 2014-02-11 Pharmacological ophthalmic composition for use in the correction of presbyopia and its administration

Publications (1)

Publication Number Publication Date
HK1232159A1 true HK1232159A1 (zh) 2018-01-05

Family

ID=50513410

Family Applications (1)

Application Number Title Priority Date Filing Date
HK17105973.1A HK1232159A1 (zh) 2014-02-11 2017-06-15 用於矯正老視的藥理學眼科用組合物和其施用

Country Status (9)

Country Link
US (1) US20170007637A1 (zh)
EP (1) EP3104851A1 (zh)
JP (1) JP2017505805A (zh)
CN (1) CN106456584A (zh)
AU (1) AU2014382677A1 (zh)
CA (1) CA2939427A1 (zh)
HK (1) HK1232159A1 (zh)
RU (1) RU2016136333A (zh)
WO (1) WO2015122853A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL264664B2 (en) * 2016-08-19 2023-03-01 Orasis Pharmaceuticals Ltd Ophthalmic pharmaceutical preparations and uses related to them
JP2018035075A (ja) * 2016-08-29 2018-03-08 株式会社Ｌｔｔバイオファーマ ドライアイ治療剤
HUE058931T2 (hu) 2018-04-24 2022-09-28 Allergan Inc Pilokarpin hidroklorid alkalmazása presbyopia kezelésére
MX2020012116A (es) * 2020-11-12 2022-08-09 Cesar Alejandro Sanchez Galeana Composicion oftalmologica sinergica en dosis de baja concentracion eficaz en la prevencion, control y erradicacion de la presbicia.
WO2023069037A1 (en) * 2021-10-19 2023-04-27 Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi Ophthalmic formulations for treatment of presbyopia, dry eye disease and computer vision syndrome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
US6291466B1 (en) * 1998-07-30 2001-09-18 Allergan Sales, Inc. Cholinergic agents in the treatment of presbyopia
CN1634123A (zh) * 2004-10-15 2005-07-06 凌沛学 含卵磷脂和玻璃酸钠的眼科给药系统及其制备方法
PT1938839E (pt) * 2006-12-18 2009-09-30 Jorge Luis Benozzi Composições oftálmicas de estimulantes parassimpáticos e anti-inflamatórios para utilização no tratamento de presbiopia
US8404270B2 (en) 2009-12-23 2013-03-26 Alimera Sciences, Inc. Method of reducing incidence of intraocular pressure associated with intraocular use of corticosteroids
US10507245B2 (en) * 2012-07-19 2019-12-17 Luis Felipe Vejarano Restrepo Ophthalmic formulation and method for ameliorating presbyopia

Also Published As

Publication number Publication date
RU2016136333A (ru) 2018-03-15
RU2016136333A3 (zh) 2018-03-15
CN106456584A (zh) 2017-02-22
US20170007637A1 (en) 2017-01-12
AU2014382677A1 (en) 2016-09-01
CA2939427A1 (en) 2015-08-20
WO2015122853A1 (en) 2015-08-20
EP3104851A1 (en) 2016-12-21
JP2017505805A (ja) 2017-02-23

Similar Documents

Publication Publication Date Title
IL249643A0 (en) Eye preparation
RS63282B1 (sr) Kompozicije i postupci za smanjenje očne neovaskularizacije
HK1254338A1 (zh) 儲存穩定的組合物及治療眼睛屈光不正的方法
HK1216146A1 (zh) 眼藥組合物、其製備方法及用途
HK1232159A1 (zh) 用於矯正老視的藥理學眼科用組合物和其施用
IL252560B (en) Heterocyclic derivatives and their uses
SG11201708114SA (en) Ophthalmic compositions and methods of use therefor
PL3452075T3 (pl) Oftalmiczna kompozycja farmaceutyczna
PL3277280T3 (pl) Izomiosmina do zastosowania w leczeniu chorób autoimmunologicznych
IL248855A0 (en) S-pyralindole and its pharmaceutically acceptable salts for use in medicine
IL246855A0 (en) Materials for use in the treatment of retinitis
HK1225994A1 (zh) 用於治療過敏性病症的組合物
IL248854A0 (en) R-pyralindole and its pharmaceutically acceptable salts for use in medicine
GB201406172D0 (en) Therapy and pharmaceutical composition
PT2944309T (pt) Utilização de palmitoiletanolamida em combinação com opióides
PL3229780T3 (pl) Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka
PL3297626T3 (pl) Kompozycja oftalmiczna zawierająca kwas liponowy i kwas hialuronowy
ZA201703701B (en) Ophthalmic composition
GB2571647B (en) The use of dipropylene/diethylene glycol dibenzoate to reduce eye irritation
GB201513543D0 (en) Compositions for use in the treatment of diabetes
PL3370727T3 (pl) Nieulegające biokonwersji c3-podstawione pochodne pregnenolonu do zastosowania w leczeniu zaburzeń związanych z nadużywaniem substancji
GB201413538D0 (en) Ophthalmic compositions and uses thereof
ZA201408464B (en) Composition for the use in treatment of asthma
ZA201403688B (en) Preservative free ophthalmic pharmaceutical composition containing dorzolamide and timolol